Zai Lab Story

Zai Lab Limited -- USA Stock  

USD 21.78  0.64  3.03%

Macroaxis does not monitor all media channels or aggregates social signals for Zai Lab. But even though we do not provide professional-grade financial sentiment analysis on Zai Lab Limited, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Zai Lab. See also Zai Lab Hype Analysis, Zai Lab Correlation and Zai Lab Performance
Zai Lab Limited to present at the 36th Annual JP Morgan Healthcare Conference
Zai Lab is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.

Read More...   

Story Momentum

This media report from distributed on January 3, 2018 was a factor to the next trading day price decrease.The trading date delta against the next closing price was 1.12% . The trading date delta when the story was published against the current closing price is 6.04% .

Similar stores for Zai Lab

Did you try this?

Run Money Managers Now

Money Managers

Screen money managers from public funds and ETFs managed around the world
Hide  View All  NextLaunch Money Managers

Number of Shares Shorted

Number of Shares Shorted Comparative Analysis
  Number of Shares Shorted 
      Zai Lab Comparables 
Zai Lab is currently under evaluation in number of shares shorted category among related companies. Number of Shares Shorted is total amount of shares that are currently sold short by investors. When stock is sold short, the short seller assumes the responsibility of buying the stock back at a lower price. The speculator will make money if the stock goes down in price or will experience loss if the stock price goes up.